Michael Gould to Cost-Benefit Analysis
This is a "connection" page, showing publications Michael Gould has written about Cost-Benefit Analysis.
Connection Strength
0.609
-
Multilevel Barriers to the Successful Implementation of Lung Cancer Screening: Why Does It Have to Be So Hard? Ann Am Thorac Soc. 2017 Aug; 14(8):1261-1265.
Score: 0.136
-
Effectiveness and cost effectiveness of thrombolysis in patients with acute pulmonary embolism. Curr Opin Pulm Med. 2008 Sep; 14(5):422-6.
Score: 0.073
-
Omalizumab for severe allergic asthma: dollars and sense. J Allergy Clin Immunol. 2007 Nov; 120(5):1015-7.
Score: 0.069
-
Effectiveness and cost-effectiveness of thrombolysis in submassive pulmonary embolism. Arch Intern Med. 2007 Jan 08; 167(1):74-80.
Score: 0.065
-
Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules. Ann Intern Med. 2003 May 06; 138(9):724-35.
Score: 0.051
-
Lung cancer screening debate. Chest. 2003 Feb; 123(2):653-4; author reply 654-5.
Score: 0.050
-
Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis. Ann Intern Med. 1999 May 18; 130(10):789-99.
Score: 0.039
-
Strategy and cost in investigating solitary pulmonary nodules. Thorax. 1998 Aug; 53 Suppl 2:S32-7.
Score: 0.036
-
Economic evaluation of the prophylaxis for thromboembolism in critical care trial (E-PROTECT): study protocol for a randomized controlled trial. Trials. 2014 Dec 20; 15:502.
Score: 0.028
-
Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patients. JAMA. 2014 Nov 26; 312(20):2135-45.
Score: 0.028
-
Screening and prevention of venous thromboembolism in critically ill patients: a decision analysis and economic evaluation. Am J Respir Crit Care Med. 2011 Dec 01; 184(11):1289-98.
Score: 0.023
-
Usefulness of positron emission tomography imaging in the management of lung cancer. Curr Opin Pulm Med. 1999 Jul; 5(4):201-7.
Score: 0.010